what is the downside of glp 1 GLP-1 Medications Infographic GLP-1 agonists and changes in

One potential mechanism could be increased prevalence of NAION risk factors in patients starting GLP-1RA or that sudden and rapid decline in blood glucose could increase the risk of diabetic papillopathy or worsened DR

More than half of all adverse drug events were classified as not serious

It comes in two dosage formulations : Formulation R1: 3 mg, 7 mg, 14 mg Formulation R2: 1.5 mg, 4 mg, 9 mg Your healthcare provider will prescribe one of these formulations for you

Still, try to stay consistent for best results

Interpregnancy care

This limited study can't answer every safety question, especially for newborns or exclusively breastfed babies